Variant report
Variant | esv1828524 |
---|---|
Chromosome Location | chr1:72755430-72788690 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:49)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:49 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:72762099-72762426 | Hela-S3 | cervix: | n/a | n/a |
2 | CTCF | chr1:72764613-72764713 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CTCF | chr1:72788357-72788474 | MCF-7 | breast: | n/a | n/a |
4 | CTCF | chr1:72788280-72788430 | SAEC | small airway: | n/a | n/a |
5 | CTCF | chr1:72788360-72788510 | SAEC | small airway: | n/a | n/a |
6 | CTCF | chr1:72788380-72788530 | HEEpiC | esophagus: | n/a | n/a |
7 | CTCF | chr1:72764612-72764712 | HepG2 | liver: | n/a | n/a |
8 | CTCF | chr1:72788343-72788498 | NHEK | skin: | n/a | n/a |
9 | CTCF | chr1:72788366-72788461 | GM19239 | blood: | n/a | n/a |
10 | CTCF | chr1:72764636-72764722 | MCF-7 | breast: | n/a | n/a |
11 | CTCF | chr1:72788280-72788430 | HMEC | breast: | n/a | n/a |
12 | CTCF | chr1:72788357-72788495 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr1:72764667-72764718 | LNCaP | prostate: | n/a | n/a |
14 | CTCF | chr1:72788394-72788437 | Pancreas_OC | pancreas: | n/a | n/a |
15 | CTCF | chr1:72788380-72788530 | RPTEC | kidney: | n/a | n/a |
16 | CTCF | chr1:72764520-72764670 | HepG2 | liver: | n/a | n/a |
17 | CTCF | chr1:72788420-72788570 | HMEC | breast: | n/a | n/a |
18 | CTCF | chr1:72788320-72788470 | HepG2 | liver: | n/a | n/a |
19 | CTCF | chr1:72788320-72788470 | RPTEC | kidney: | n/a | n/a |
20 | CTCF | chr1:72764591-72764610 | HepG2 | liver: | n/a | n/a |
21 | EP300 | chr1:72762099-72762511 | SK-N-SH_RA | brain: | n/a | n/a |
22 | EP300 | chr1:72761930-72762734 | SK-N-SH | brain: | n/a | chr1:72762565-72762574 |
23 | FOS | chr1:72762452-72762725 | MCF10A-Er-Src | breast: | n/a | chr1:72762565-72762574 chr1:72762565-72762572 chr1:72762564-72762574 chr1:72762564-72762574 |
24 | GATA2 | chr1:72762098-72762619 | SH-SY5Y | brain: | n/a | n/a |
25 | GATA3 | chr1:72762039-72762726 | SH-SY5Y | brain: | n/a | n/a |
26 | GATA3 | chr1:72762060-72762709 | SK-N-SH | brain: | n/a | n/a |
27 | GATA3 | chr1:72761978-72762789 | SK-N-SH | brain: | n/a | n/a |
28 | MAFF | chr1:72758320-72758517 | K562 | blood: | n/a | chr1:72758439-72758457 |
29 | MAFF | chr1:72758369-72758595 | HepG2 | liver: | n/a | chr1:72758439-72758457 |
30 | MAFF | chr1:72768956-72769184 | HepG2 | liver: | n/a | chr1:72769041-72769059 |
31 | MAFK | chr1:72758355-72758555 | K562 | blood: | n/a | chr1:72758440-72758455 |
32 | MAFK | chr1:72768954-72769154 | HepG2 | liver: | n/a | chr1:72769042-72769056 chr1:72769043-72769058 chr1:72769044-72769064 chr1:72769044-72769055 chr1:72769044-72769055 |
33 | MAFK | chr1:72768925-72769194 | IMR90 | lung: | n/a | chr1:72769042-72769056 chr1:72769043-72769058 chr1:72769044-72769064 chr1:72769044-72769055 chr1:72769044-72769055 |
34 | MAFK | chr1:72768938-72769209 | HepG2 | liver: | n/a | chr1:72769042-72769056 chr1:72769043-72769058 chr1:72769044-72769064 chr1:72769044-72769055 chr1:72769044-72769055 |
35 | MAFK | chr1:72766205-72766217 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | MAFK | chr1:72758406-72758564 | HepG2 | liver: | n/a | chr1:72758440-72758455 |
37 | MAFK | chr1:72758276-72758594 | IMR90 | lung: | n/a | chr1:72758440-72758455 |
38 | MAFK | chr1:72758307-72758596 | HepG2 | liver: | n/a | chr1:72758440-72758455 |
39 | PBX3 | chr1:72762067-72762577 | SK-N-SH | brain: | n/a | n/a |
40 | POLR2A | chr1:72770426-72770465 | HUVEC | blood vessel: | n/a | n/a |
41 | POLR2A | chr1:72760584-72760710 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr1:72786325-72786407 | ProgFib | skin: | n/a | n/a |
43 | POLR2A | chr1:72781174-72781265 | ProgFib | skin: | n/a | n/a |
44 | POLR2A | chr1:72759059-72759131 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | SMC3 | chr1:72788302-72788496 | HepG2 | liver: | n/a | n/a |
46 | STAT3 | chr1:72778843-72779010 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | STAT3 | chr1:72758536-72758617 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | TCF7L2 | chr1:72762191-72762648 | Hela-S3 | cervix: | n/a | chr1:72762564-72762573 |
49 | TEAD4 | chr1:72762092-72762488 | SK-N-SH | brain: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL31P12 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12739274 | chr1:72755430-72755431 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181833841 | chr1:72755474-72755475 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562125036 | chr1:72755476-72755477 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs148693664 | chr1:72755496-72755497 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551462558 | chr1:72755567-72755568 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186393381 | chr1:72755572-72755573 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540070097 | chr1:72755579-72755580 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546867526 | chr1:72755581-72755582 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs11209944 | chr1:72755591-72755592 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs182948602 | chr1:72755596-72755597 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556067493 | chr1:72755606-72755607 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575724230 | chr1:72755634-72755635 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537810192 | chr1:72755638-72755639 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558235394 | chr1:72755651-72755652 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200941555 | chr1:72755696-72755697 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs186179397 | chr1:72755727-72755728 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540463114 | chr1:72755817-72755818 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs79445361 | chr1:72755840-72755841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536223351 | chr1:72755900-72755901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116239385 | chr1:72755919-72755920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573628211 | chr1:72755954-72755955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542537000 | chr1:72755964-72755965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377736179 | chr1:72755988-72755989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531336884 | chr1:72756028-72756029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551085610 | chr1:72756031-72756032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17526367 | chr1:72756049-72756050 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs527378781 | chr1:72756065-72756066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs547242651 | chr1:72756069-72756070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567091027 | chr1:72756072-72756073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2568950 | chr1:72756099-72756100 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs191425154 | chr1:72756145-72756146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs569526117 | chr1:72756161-72756162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs71653514 | chr1:72756295-72756296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531863519 | chr1:72756312-72756313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs183208297 | chr1:72756316-72756317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557858775 | chr1:72756327-72756328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs199723277 | chr1:72756355-72756356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578075148 | chr1:72756370-72756371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573279485 | chr1:72762013-72762014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs80109987 | chr1:72762040-72762041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182348893 | chr1:72762053-72762054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs575647607 | chr1:72762081-72762082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185684012 | chr1:72762125-72762126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs34581627 | chr1:72762156-72762157 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs541417645 | chr1:72762158-72762159 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs141831036 | chr1:72762165-72762166 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs2568955 | chr1:72762169-72762170 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs190149915 | chr1:72762235-72762236 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs370824110 | chr1:72762285-72762286 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs563338419 | chr1:72762339-72762340 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:72752000-72755800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr1:72754400-72755600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
3 | chr1:72754800-72755800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr1:72754800-72756400 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr1:72755200-72755800 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
6 | chr1:72755200-72755800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
7 | chr1:72755400-72755800 | Flanking Active TSS | Dnd41 | blood |
8 | chr1:72755400-72756200 | Enhancers | Thymus | Thymus |
9 | chr1:72755800-72756000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr1:72755800-72756200 | Enhancers | Dnd41 | blood |
11 | chr1:72755800-72756400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
12 | chr1:72762000-72762200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr1:72762200-72762800 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr1:72762800-72763000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr1:72763200-72763600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
16 | chr1:72763200-72764000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
17 | chr1:72788200-72788800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |